<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bcl-2-associated athanogene 3 (Bag-3) belongs to a member of the Hsc70 binding co-chaperone Bag-family proteins and has critical roles in protein homeostasis, cell survival, actin organization, cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, cell motility and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">tumor metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To clarify the role of Bag-3 in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and subsequent development, its expression was examined by immunohistochemistry (IHC) and in situ hybridization (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) on tissue microarrays containing colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, <z:mpath ids='MPATH_270'>adenomas</z:mpath>, non-neoplastic mucosa (NNM) and metastatic <z:mp ids='MP_0002038'>carcinomas</z:mp> in lymph node and liver </plain></SENT>
<SENT sid="2" pm="."><plain>Colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> tissue and cell lines were studied for Bag-3 expression by RT-PCR, Western blot and immunofluorescence </plain></SENT>
<SENT sid="3" pm="."><plain>The results demonstrated that Bag3 was distinctly expressed in Colo201, Colo205, DLD-1, HCT-15, HCT-116, HT-29, KM-12, SW480, SW620, and WiDr at both <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0002038'>Carcinoma</z:mp> showed stronger Bag-3 expression than adjacent NNM by IHC and Western blot (P⟨0.05), while its <z:chebi fb="2" ids="33699">mRNA</z:chebi> had the opposite by real-time PCR and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> (P⟨0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Metastatic <z:mp ids='MP_0002038'>carcinoma</z:mp> more frequently expressed Bag-3 mRNA in lymph node and liver than in primary <z:mp ids='MP_0002038'>carcinoma</z:mp> (P⟨0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemically, Bag-3 expression was seen to gradually decrease in samples from <z:mp ids='MP_0002038'>carcinoma</z:mp> <z:mpath ids='MPATH_270'>adenoma</z:mpath> to NNM (P⟨0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>There was a positive correlation between Bag-3 expression and TNM staging and GRP94 expression (P⟨0.05), but no relationship to patient age or sex, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, depth of invasion, lymphatic or venous invasion, lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, differentiation or prognosis of colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (P⟩0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Our study indicated that aberrant Bag-3 expression might be involved in colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence and subsequent progression </plain></SENT>
</text></document>